Skip to main content
OpenTrials
Completed

NCT Number: NCT02072655

Impact of Socio-aesthetic Care in the Quality of Life of Patients Treated for Lymphoma During and After Hospitalization

In the early 2000s , professional and patient organizations are mobilizing to highlight the psychosocial impact of cancer disease , not only during but also after the acute phase.

In 2003, the government launched the Cancer Plan I reinforced in December 2011 by the Cancer Plan II whose objectives include : " Develop a personalized care taking into account the pain and psychological and social support " and " increase opportunities for patients to benefit from supportive care "and" promote the professional integration .

This study aims to show that beyond the immediate benefits of the social aesthetic cares in hospital (direct soothing, improving the quality of the skin injured by chemotherapy , feeling of escape ... ), these treatments can also affect quality of life for patients during and after hospitalization. They also may have an impact on the maintenance of social and / or professional satisfactory throughout the planned chemotherapy aplastic period .

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Lymphoma Hemic and Lymphatic Diseases Immune System Diseases Immunoproliferative Disorders Lymphatic Diseases Lymphoproliferative Disorders Neoplasms Neoplasms by Histologic Type

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hematology Care Unit - UH Angers

Angers, 49000, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 to 65 years old
  • Hospitalized in the Hematology care unit in UH Angers
  • Initial Hodgkin lymphoma, diffuse large B-cell lymphoma and mantle cell lymphoma
  • Without previous socio-aesthetic care.

Exclusion criteria

  • Age <18 years old.
  • Patient protected by the law.
  • Patient at end of life.
  • Patient unable to respond to the questionnaire.
  • Previous Socio aesthetic care.

Treatment and study plan

socio-aesthetic care

Procedure
  • care of the face
  • skin cleansing with cleansing milk to remove impurities
  • a gentle scrub to exfoliate and cleanse the skin
  • a relaxing massage
  • moisturizing mask
  • application of a moisturizer suited to specific patient skin: skin reactivity, dehydration ...
  • care manicure / pedicure,
  • massages
  • makeup, advice (scarves, wigs care products adapted to the skin changes ...) and helping relationship.

Primary outcomes

  1. Quality of life score

    Time frame: Change form baseline in Quality of life score at an average of 5 months (4 to 6 cycles of chemotherapy).

    • For patients in control group, arbitrarily during their fifth cycle of chemotherapy
    • For patients in interventional group during the course of chemotherapy after the third socio-aesthetic care, or at the latest, at the sixth treatment.

Secondary outcomes

  1. Coopersmith Self-esteem inventory

    Time frame: Change form baseline in Coopersmith Self-esteem inventory score at an average of 5 months (4 to 6 cycles of chemotherapy).

  2. Body Image Scale assessment

    Time frame: Change form baseline in body image scale assessment score at an average of 5 months (4 to 6 cycles of chemotherapy).

  3. Social life assessment

    Time frame: Change form baseline in social life assessment score at an average of 5 months (4 to 6 cycles of chemotherapy).

Sponsors and collaborators

Lead sponsor

University Hospital, Angers

Other Gov

Registry information

Acronym: CareSSE

Important dates

Study start
2014
Primary completion
2016
Study completion
2016
First posted
Feb 26, 2014
Registry last updated
Jun 16, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.